Niche diagnostics Target opportunities in molecular diagnostics for infectious diseases and biothreat agents, leveraging Ionian Technologies' specialized focus to offer scalable lab workflows, assay development services, and deployment support for rapid testing programs.

Acquisition leverage Position offerings around integration with larger healthcare and diagnostic ecosystems, highlighting synergies with parent company Alere Inc. and potential for scaled distribution, validation pipelines, and joint go-to-market strategies.

Cloud and web stack Prospect for cloud-based data management, secure analytics, and API-driven lab integration using AWS, HTTP/3, Apache, and Nginx to support remote diagnostics, data sharing, and scalable hosting for assay platforms.

Growth within biotech clients Explore services and tools tailored to small biotech with high growth potential, offering modular solutions such as reagent design support, assay validation, and compliance-ready software to accelerate product development timelines.

Funding signals Leverage the mid-market revenue profile to pitch cost-effective partnerships, pilot programs, and revenue-share models with lab networks and regional distributors looking to expand infectious disease testing capabilities.